2019年科研论文发表情况
发布时间：2022-04-01
| 序号 | 发表论文年度月份 | 作者 | 通讯作者 | 完成单位信息 | 论文题目 |
| 1 | 2019/3 | 宋孟秋, Ann M Bode | 董子钢 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Mengqiu Song#, Ann M Bode#, Zigang Dong, Mee-Hyun Lee. AKT as a Therapeutic Target for Cancer. Cancer Res. 2019 Mar 15;79(6):1019-1031. |
| 2 | 2019/9 | 马朝斌，祖雪银 | 刘珍珍，Dong Joon Kim | 郑州大学附属肿瘤医院，中美（河南）荷美尔肿瘤研究院，郑州大学基础医学院 | Chaobing Ma, Xueyin Zu, Kangdong Liu , Ann M Bode, Zigang Dong, Zhenzhen Liu, Dong Joon Kim. Knockdown of Pyruvate Kinase M Inhibits Cell Growth and Migration by Reducing NF-kB Activity in Triple-Negative Breast Cancer Cells. Mol Cells. 2019 Sep 30;42(9):628-636. |
| 3 | 2019/3 | 田雪利，顾廷轩 | 董子钢，Mee-Hyun Lee | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Xueli Tian #, Tingxuan Gu #, Satyananda Patel, Ann M Bode, Mee-Hyun Lee, Zigang Dong. CRISPR/Cas9 - An evolving biological tool kit for cancer biology and oncology. NPJ Precis Oncol. 2019 Mar 18;3:8. |
| 4 | 2019/12 | 张天顺，白瑞华，王秋实，王可可 | 董子钢 | 明尼苏达大学荷美尔研究院，中美（河南）荷美尔肿瘤研究院 | Tianshun Zhang #, Ruihua Bai #, Qiushi Wang #, Keke Wang #, Xiang Li, Kangdong Liu, Joohyun Ryu, Ting Wang, Xiaoyu Chang, Weiya Ma, Ann M Bode, Qingxin Xia, Yongping Song, Zigang Dong. Fluvastatin Inhibits HMG-CoA Reductase and Prevents Non-Small Cell Lung Carcinogenesis. Cancer Prev Res (Phila). 2019 Dec;12(12):837-848. |
| 5 | 2019/6 | 赵四敏 | 董子钢 | 明尼苏达大学荷美尔研究院，中美（河南）荷美尔肿瘤研究院 | Simin Zhao, Ke Yao, Dan Li, Kangdong Liu, Guoguo Jin, Mingyang Yan, Qiong Wu, Hanyong Chen, Seung Ho Shin, Ruihua Bai, Gangcheng Wang, Ann M Bode, Ziming Dong, Zhiping Guo, Zigang Dong. Inhibition of LTA4H by bestatin in human and mouse colorectal cancer. EBioMedicine. 2019 Jun;44:361-374. |
| 6 | 2019/4 | 田雪利 | 董子钢，Dong Joon Kim | 郑州大学附属肿瘤医院，中美（河南）荷美尔肿瘤研究院，郑州大学基础医学院 | Xueli Tian, KangDong Liu, Xueyin Zu, Fayang Ma, Zhi Li, MeeHyun Lee, Hanyong Chen, Yan Li, Yuzhou Zhao, Fangfang Liu, Naomi Oi, Ann M Bode, Zigang Dong, Dong Joon Kim. 3,3'-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2. Cancer Lett. 2019 Apr 28;448:20-30. |
| 7 | 2019/12 | 刘飞飞 | 董子钢，Dong Joon Kim | 中美（河南）荷美尔肿瘤研究院 | Feifei Liu, Xueyin Zu, Xiaomeng Xie, Yuanyuan Zhang, Kangdong Liu, Hanyong Chen, Ting Wang, Ann M Bode, Zigang Dong, Dong Joon Kim. Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma.Cancer Prev Res (Phila). 2019 Dec;12(12):849-860. |
| 8 | 2019/8 | 刘雪娇，宋孟秋，王鹏磊 | 董子钢，Mee-Hyun Lee | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Xuejiao Liu#, Mengqiu Song#, Penglei Wang#, Ran Zhao, Hanyong Chen, Man Zhang, Yuanyuan Shi, Kangdong Liu, Fangfang Liu, Ran Yang, Enmin Li, Ann M Bode, Zigang Dong, Mee-Hyun Lee. Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo. Int J Cancer. 2019 Aug 15;145(4):1007-1019. |
| 9 | 2019/4 | 刘飞飞 | 董子钢，Dong Joon Kim | 中美（河南）荷美尔肿瘤研究院 | Feifei Liu, Xueyin Zu, Xiaomeng Xie, Kangdong Liu, Hanyong Chen, Ting Wang, Fangfang Liu, Ann M Bode, Yan Zheng, Zigang Dong, Dong Joon Kim. Ethyl gallate as a novel ERK1/2 inhibitor suppresses patient-derived esophageal tumor growth. Mol Carcinog. 2019 Apr;58(4):533-543. |
| 10 | 2019/3 | 王利 | 董子钢，Dong Joon Kim | 中美（河南）荷美尔肿瘤研究院 | Li Wang, Xiangyu Wang, Hanyong Chen, Xueyin Zu, Fayang Ma, Kangdong Liu, Ann M Bode, Zigang Dong, Dong Joon Kim. Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2. Phytother Res. 2019 Mar;33(3):640-650. |
| 11 | 2019/12 | 宋孟秋，殷淑英 | 董子钢，Mee-Hyun Lee | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Mengqiu Song, Shuying Yin, Ran Zhao, Kangdong Liu, Joydeb Kumar Kundu, Jung-Hyun Shim, Mee-Hyun Lee, Zigang Dong. (S)-10-Hydroxycamptothecin Inhibits Esophageal Squamous Cell Carcinoma Growth In Vitro and In Vivo Via Decreasing Topoisomerase I Enzyme Activity. Cancers (Basel). 2019 Dec 6;11(12):1964. |
| 12 | 2019/7 | 谢宵梦 | 董子钢，Dong Joon Kim | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Xiaomeng Xie, Xueyin Zu, Feifei Liu, Ting Wang, Xiangyu Wang, Hanyong Chen, Kangdong Liu, Penglei Wang, Fangfang Liu, Yan Zheng, Ann M. Bode, Zigang Dong, Dong Joon Kim. Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo. Mol Carcinog. 2019 Jul;58(7):1248-1259. |
| 13 | 2019/7 | Marco,Pilar | 董子钢,刘康栋 | 中美（河南）荷美尔肿瘤研究院 | Marco Pirisinu, Pilar Blasco, Xueli Tian, Yang Sen, Ann M Bode, Kangdong Liu, Zigang Dong. Analysis of hydrophobic and hydrophilic moments of short penetrating peptides for enhancing mitochondrial localization: prediction and validation. FASEB J. 2019 Jul;33(7):7970-7984. |
| 14 | 2019/9 | 祖雪银 | 董子钢，Dong Joon Kim | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Xueyin Zu, Xiaomeng Xie, Yuanyuan Zhang, Kangdong Liu, Ann M Bode 5 , Zigang Dong, Dong Joon Kim. Lapachol is a novel ribosomal protein S6 kinase 2 inhibitor that suppresses growth and induces intrinsic apoptosis in esophageal squamous cell carcinoma cells. Phytother Res. 2019 Sep;33(9):2337-2346. |
| 15 | 2019/2 | 谢宵梦 | 董子钢，Dong Joon Kim | 中美（河南）荷美尔肿瘤研究院 | Xiaomeng Xie, Kangdong Liu, Feifei Liu, Hanyong Chen, Xiangyu Wang, Xueyin Zu, Xiaoli Ma, Ting Wang, Qiong Wu, Yan Zheng, Ann M Bode, Zigang Dong, Dong Joon Kim. Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo. Cancer Lett. 2019 Feb 1;442:126-136. |
| 16 | 2019/8 | 赵冉，黄海，Bu Young Choi | 董子钢，Mee-Hyun Lee | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Ran Zhao#, Hai Huang#, Bu Young Choi#, Xuejiao Liu, Man Zhang, Silei Zhou, Mengqiu Song, Fanxiang Yin, Hanyong Chen, Jung-Hyun Shim, Ann M Bode, Zigang Dong, Mee-Hyun Lee. Cell growth inhibition by 3-deoxysappanchalcone is mediated by directly targeting the TOPK signaling pathway in colon cancer. Phytomedicine. 2019 Aug;61:152813. |
上一篇： 2020年科研论文发表情况
下一篇： 2018年科研论文发表情况
